Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Promising New Drugs and Combinations. Fulfilling Our Pledge.

Chabner1

  • 1Department of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts, 02114-2617, USA. chabner.bruce@mgh.harvard.edu

The Oncologist
|November 5, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

About sorrow

The oncologist·2000
Same author

ASCO 1998: A Commentary.

The oncologist·1999
Same author

Schwartz Center Rounds. A Staff Dialogue on Phase I Trials: Psychosocial Issues Faced by Patients, Their Families, and Caregivers.

The oncologist·1999
Same author

Schwartz Center Rounds. A Staff Dialogue on Caring for an Intensely Spiritual Patient: Psychosocial Issues Faced By Patients, Their Families, and Caregivers.

The oncologist·1999
Same author

Current Management of Patients with Ductal Carcinoma-in-Situ.

The oncologist·1997
Same author

Cancer: A Personal Journey. Notes from the Edge.The Diary of Peter J. Morgan, M.D.

The oncologist·1997

The Oncologist journal introduces a new section on promising cancer drugs. This section will provide oncologists with essential information on new treatments as they approach marketing status.

Area of Science:

  • Oncology
  • Pharmacology
  • Clinical Research

Background:

  • The field of oncology is experiencing rapid advancements in treatment approaches.
  • New knowledge regarding cancer's causes fuels the development of novel therapies.
  • The increasing pace of research presents challenges for practicing oncologists.

Purpose of the Study:

  • To address the challenge of rapidly evolving cancer treatments for practicing oncologists.
  • To provide timely access to essential information on new and promising cancer drugs.
  • To establish a dedicated section in The Oncologist journal for new drug information.

Main Methods:

  • The Oncologist journal's board of editors will develop a new section.
  • The section will be devoted to "Promising New Drugs and Combinations."

Related Experiment Videos

  • Experienced clinical researchers will edit and oversee the new section.

    • Main Results:

    • The new section aims to ensure readership has essential information on drugs nearing marketing status.
    • It will cover a variety of novel cancer therapeutics including antibodies, differentiating agents, and targeted therapies.
    • Information will include drug biology, pharmacology, clinical uses, risks, benefits, and interactions.

    Conclusions:

    • The new section in The Oncologist will be a vital resource for oncologists.
    • It will facilitate the understanding and application of emerging cancer treatments.
    • The journal seeks reader feedback to ensure relevance and timeliness of information.